Brief: Merck Q1 Adjusted Loss Per Share $1.28 Versus IBES Estimate $-1.51

Merck & Co

30/04/2026 11:30

April 30 (Reuters) - Merck & Co Inc MRK.N:

MERCK Q1 ADJUSTED LOSS PER SHARE $1.28 VERSUS IBES ESTIMATE $-1.51

MERCK OUTLOOK 2026 WORLDWIDE SALES $65.8 BILLION TO $67 BILLION VERSUS IBES ESTIMATE $66.61 BILLION

MERCK OUTLOOK 2026 ADJUSTED EPS $5.04 TO $5.16 VERSUS IBES ESTIMATE $5.11

MERCK: Q1 GAAP & NON-GAAP LOSS PER SHARE INCLUDE $3.62 PER SHARE CHARGE FOR ACQUISITION OF CIDARA

MERCK Q1 WORLDWIDE SALES $16.29 BILLION VERSUS IBES ESTIMATE $15.82 BILLION

MERCK Q1 KEYTRUDA SALES $8 BILLION VERSUS IBES ESTIMATE $7.62 BILLION

Further company coverage: MRK.N

 ((Reuters.Briefs@thomsonreuters.com;))